Alpinia Essential Oils and Their Major Components against Rhodnius nasutus, a Vector of Chagas Disease
Table 2
Mass difference (mg) before and after feeding observed in R. nasutus treated with OLALPVIT and OLALPZER at 125 µg/µL under laboratory conditions.
Groups (treatments)
1st week
2nd week
3rd week
4th week
5th week
6th week
χ ± SD
IV
χ ± SD
IV
χ ± SD
IV
χ ± SD
IV
χ ± SD
IV
χ ± SD
IV
Pure control
10.6 ± 4.5
0–114
7.8 ± 12.7
0–14
16.0 ± 26.7
0–104
28.9 ± 41.3
0–124
2.6 ± 5.8
0–24
12.0 ± 26.6
0–107
DMSO control
8.8 ± 2.9
0–54
6.4 ± 12.7
0–58
21.7 ± 41.1
0–140
14.5 ± 24.2
0–89
5.7 ± 9.2
0–29
3.6 ± 7.3
0–27
OLALPVIT
0.0 ± 0.0
0-0
0.0 ± 0.0
0-0
0.0 ± 0.0
0-0
0.0 ± 0.0
0-0
0.0 ± 0.0
0-0
0.0 ± 0.0
0-0
OLALPZER
0.0 ± 0.0
0-0
0.0 ± 0.0
0-0
0.0 ± 0.0
0-0
0.0 ± 0.0
0-0
0.0 ± 0.0
0-0
0.0 ± 0.0
0-0
χ, means; SD, standard deviation; IV, interval variation (range). Means followed by the same letter within each column are not significantly different according to Tukey’s test ( < 0.05).
